|Articles|March 2, 2017
OmniComm, Bio-Optronics to Provide Solutions for Children's Cancer Center
Omnicomm Systems and Bio-Optronics have reached an agreement to integrate OmniComm’s TrialMaster EDC with Bio-Optronics CTMS solution for multiple facilities at a children’s health institution.
Advertisement
Omnicomm Systems and Bio-Optronics have reached an agreement to integrate OmniComm’s TrialMaster EDC with Bio-Optronics CTMS solution for multiple facilities at a children’s health institution seeking to develop cures and treatments for cancer and other diseases.
Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Ensuring Digital Trial Platforms Work for Underserved CommunitiesSeptember 10th 2025
eClinical Technology: Misconceptions, Challenges, and OpportunitiesSeptember 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial
2
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
3
eClinical Technology: Misconceptions, Challenges, and Opportunities
4
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
